Literature DB >> 24614722

Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome.

Marcus Dabner1, Robert J McClure, Nathan T Harvey, Charley A Budgeon, Trevor W Beer, Benhur Amanuel, Benjamin A Wood.   

Abstract

The aim of this study was to determine the frequency of Merkel cell polyomavirus (MPyV) and p63 positivity by immunohistochemistry in a large cohort of primary Merkel cell carcinoma (MCC) from a region with high rates of actinic damage. We also aimed to determine whether there is any relationship between these markers and histological correlates of chronic sun exposure and to identify whether these markers have prognostic significance in our population. Ninety-five cases of primary cutaneous MCC were identified and stained with immunohistochemical markers for MPyV and p63. The presence of solar elastosis and squamous dysplasia in the overlying/adjacent skin were recorded as markers of actinic damage. Follow up data were obtained from the Western Australian Cancer Registry. MPyV was detected by immunohistochemistry in 23% of cases. There was a statistically significantly lower rate of positivity in tumours associated with markers of chronic sun damage as assessed by the presence of solar elastosis and squamous dysplasia. There was no association with overall or disease specific survival. p63 positivity was detected in 17% of cases. There was no association with markers of actinic damage or with overall or disease specific survival.Our data demonstrate a significant difference in rates of immunohistochemical positivity for MPyV between MCC in sun-damaged and non-sun-damaged sites. This may go some way to explaining previously identified geographical differences. When compared with a number of studies from Europe and North America, p63 positivity is less common in our population and does not show the strong prognostic significance that has been found in these other regions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614722     DOI: 10.1097/PAT.0000000000000069

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

1.  Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.

Authors:  Samuel A Henderson; Michael T Tetzlaff; Penvadee Pattanaprichakul; Patricia Fox; Carlos A Torres-Cabala; Roland L Bassett; Victor G Prieto; Hunter W Richards; Jonathan L Curry
Journal:  J Cutan Pathol       Date:  2014-10-28       Impact factor: 1.587

Review 2.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 3.  From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis.

Authors:  Nathan A Krump; Jianxin You
Journal:  Front Microbiol       Date:  2021-09-08       Impact factor: 6.064

Review 4.  p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer.

Authors:  Artem Smirnov; Lucia Anemona; Flavia Novelli; Cristina M Piro; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Eleonora Candi
Journal:  Int J Mol Sci       Date:  2019-11-17       Impact factor: 5.923

Review 5.  Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America.

Authors:  Rafael A Schmerling; Jose G Casas; Gabriela Cinat; Fabio Ernesto Grosso Ospina; Luiza E B P Kassuga; Jorge Luis Martinez Tlahuel; Luis Daniel Mazzuoccolo
Journal:  J Glob Oncol       Date:  2018-07

Review 6.  Non-Melanoma Skin Cancers: Biological and Clinical Features.

Authors:  Mauro Cives; Francesco Mannavola; Lucia Lospalluti; Maria Chiara Sergi; Gerardo Cazzato; Elisabetta Filoni; Federica Cavallo; Giuseppe Giudice; Luigia Stefania Stucci; Camillo Porta; Marco Tucci
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

Review 7.  The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary.

Authors:  David L Kok; Annie Wang; Wen Xu; Margaret S T Chua; Alexander Guminski; Michael Veness; Julie Howle; Richard Tothill; Ganessan Kichendasse; Michael Poulsen; Shahneen Sandhu; Gerald Fogarty
Journal:  Asia Pac J Clin Oncol       Date:  2020-08-05       Impact factor: 2.601

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.